Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2018-10-19 | James Sapirstein, R.Ph., M.B.A., age 57, has been nominated to the Board. He has served over thirty years in the pharmaceutical industry and holds an MBA from Fairleigh Dickinson University and B.Pharm. from Rutgers University. |
Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22